Dilution of Share Value from Exercise of Stock Options
First written in FY2021. 19 of 21 entries say "Materialised", first in FY2022-Q3. Latest entry: 2026-10-01.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026WorsenedAnnual report
「The class and total number of common shares underlying these stock acquisition rights shall be 3,900,000 common shares of the Company.」
2026 stock acquisition rights with an exercise-price adjustment clause were issued, creating up to 3,900,000 potential shares. During the fiscal year, 315 rights, equivalent to 31,500 shares, were also exercised, increasing the potential dilution. - FY2026-H1MaterialisedAnnual report
「1 April 2025–30 September 2025 (Note) Increase due to the exercise of stock acquisition rights. 52,200」
The exercise of stock acquisition rights resulted in the issuance of 52,200 shares during the interim consolidated accounting period, meaning that the factor contributing to share-value dilution materialized. - FY2025-H1MaterialisedAnnual report
「1 April 2024–30 September 2024 13,600 9,664,900 3 68 3 1,787 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 13,600 shares during the interim consolidated accounting period, meaning that the factor contributing to share-value dilution materialized. - FY2024MaterialisedAnnual report
「The increase in the total number of issued common shares consisted of an increase of 64,200 shares through the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 64,200 shares during the fiscal year, meaning that the factor contributing to share-value dilution materialized. - FY2024-Q3MaterialisedAnnual report
「Change in total number of shares issued 16,700 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 16,700 shares during the third quarter, meaning that the factor contributing to share-value dilution continued to materialize. - FY2024-Q2MaterialisedAnnual report
「1 July 2023–30 September 2023 19,100 9,616,100 5 55 5 1,774 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 19,100 shares during the second quarter, meaning that the factor contributing to share-value dilution materialized. - FY2024-Q1MaterialisedAnnual report
「1 April 2023–30 June 2023 Change in total number of shares issued 9,900 shares (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 9,900 shares during the first quarter, meaning that the factor contributing to share-value dilution materialized. - FY2023MaterialisedAnnual report
「The increase in the total number of issued common shares consisted of an increase of 244,200 shares through a third-party allotment and an increase of 30,700 shares through the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 30,700 shares during the fiscal year, meaning that the factor contributing to share-value dilution materialized. An additional increase of 2,300 shares is also disclosed through the filing date. - FY2023-Q3MaterialisedAnnual report
「1 October 2022–31 December 2022 (Note) 1. Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 700 shares during the third quarter, meaning that the factor contributing to share-value dilution continued to materialize. - FY2023-Q2MaterialisedAnnual report
「1 July 2022–30 September 2022 4,700 9,326,800 1 42 1 1,761 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 4,700 shares during the second quarter, meaning that the factor contributing to share-value dilution continued to materialize as actual share issuance. - FY2023-Q1MaterialisedAnnual report
「1 April 2022–30 June 2022 Change in total number of shares issued 9,900 shares (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 9,900 shares during the quarter, meaning that the factor contributing to share-value dilution materialized again during the quarter. - FY2022MaterialisedAnnual report
「Common shares 7,777,200 1,535,000 – 9,312,200」
An increase of 35,000 shares due to the exercise of stock acquisition rights occurred during the fiscal year, meaning that the potential source of share-value dilution continued to materialize as actual share issuance. - FY2022-Q3MaterialisedAnnual report
「1 October 2021–31 December 2021 Change in total number of shares issued 4,100 shares (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 4,100 shares, meaning that a factor previously disclosed as a potential source of share-value dilution materialized as an actual share issuance. - FY2021First statedAnnual report
「If the stock acquisition rights currently granted to our directors and employees are exercised, the value of shares held may be diluted.」
A new risk has been disclosed: the exercise of stock acquisition rights granted to directors and employees may dilute the value of shares held by existing shareholders.